TTNMF yields 1.38% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, TTNMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TTNMF + JNJ for your $10,000?
Titanium Transportation Group Inc., together with its subsidiaries, provides asset-based transportation and logistics services in North America. It operates in two segments, Truck Transportation and Logistics. The Truck Transportation segment provides pickup and delivery of general merchandise by long-haul, dedicated, and local trucking services through various trailer types, including 53' dry vans, flatbeds, step-decks, heavy axle trailers, and other specialty equipment. The Logistics segment provides non-asset-based broker services, which include ancillary transportation services, such as third party logistics and freight forwarding services. This segment also provides truckload and less than truckload freight services on vans, flatbeds, and other specialty equipment; and intermodal services, international ocean and air shipping, and emergency and expedited services, as well as specialty services for hazardous and fragile products. The company also offers inventory warehousing and distribution services. It serves customers across various industries, including multinational corporations. The company was founded in 2002 and is headquartered in Bolton, Canada.
Full TTNMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.